Cargando...
Flibanserin for hypoactive sexual desire disorder: place in therapy
The pathophysiology, diagnosis and treatment of female sexual interest in pre- and post-menopausal women present a complex arena for patients and physicians to navigate. Flibanserin was the first pharmacologic treatment, approved by the United States Food and Drug Administration in August 2015, for...
Guardado en:
| Publicado en: | Ther Adv Chronic Dis |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298357/ https://ncbi.nlm.nih.gov/pubmed/28203348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316679933 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|